Dr. Chen received his bachelor degree from Fudan University(2002) followed by a Ph.D degree from eastern hepatobilliary surgery institute/hospital (EHBI/EHBH) in Second Military Medical University (SMMU)(2007), Shanghai, China, under the supervision of Professor Hongyang Wang (hywangk@vip.sina.com), with an emphasis on cancer signal transduction. After graduation, he went to National Cancer Institute（NCI, NIH） and worked as a visiting scholar from Aug. 2015 to Sep. 2016. In September 2017, Dr. Chen was recruited to Hong-yang Wang’s Academician Workstation at Cancer Institute, Fudan University Shanghai Cancer Center, and was appointed as Principal Investigator. In the past few years, he has led projects focusing on the molecular mechanism of hepatocellular carcinoma (HCC) development and progression, especially on the roles of inflammation-related hepatocytes apoptosis, liver injury and also the function of non-coding RNA. He has published over 50 papers in several journals, including Gastroenterology, Gut, Nature Communications, Hepatology, BBA Reviews on Cancer, Cancer Research, Journal of Hepatology, Journal of Virology, Molecular Cancer, FEBS Journal, Nature Cell Biology，J.E.M, J.B.C，total citations are 2120.

Research Focus:

1. The screening and validation of very early biomarkers for Liver Cancer

2. The underlying Mechanisms of development and progression of Liver Cancer